[Echocardiographic screening vs. symptomatic diagnosis for patent ductus arteriosus in preterms].

Simple item page
dc.contributor.authorGabriela Juárez-Domínguez
dc.contributor.authorJosé Iglesias-Leboreiro
dc.contributor.authorMario Enrique Rendón‐Macías
dc.contributor.authorIsabel Bernárdez-Zapata
dc.contributor.authorEmilia Patiño-Bahena
dc.contributor.authorSion Agami-Micha
dc.contributor.authorKarla Leticia Ortega-García
dc.contributor.authorGregory Torres-Palomino
dc.contributor.authorDagoberto Delgado‐Franco
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:57:26Z
dc.date.available2026-03-22T15:57:26Z
dc.date.issued2016
dc.descriptionCitaciones: 2
dc.description.abstractThe echocardiographic screening for PDA in extreme preterm newborns reduces the time to detect it, and allow to give less aggressive treatment. We do not recommend their use in moderate o late preterm newborn.
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/25760741
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/55403
dc.language.isoen
dc.publisherNational Institutes of Health
dc.relation.ispartofPubMed
dc.sourceHospital Español
dc.subjectDuctus arteriosus
dc.subjectMedicine
dc.subjectGestational age
dc.subjectPediatrics
dc.subjectSignificant difference
dc.title[Echocardiographic screening vs. symptomatic diagnosis for patent ductus arteriosus in preterms].
dc.typearticle

Files

Collections

Artículo Científico Publicado